2019年7月
PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin®), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Study.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- DOI
- 10.1007/s40259-019-00363-4
- リンク情報
- ID情報
-
- DOI : 10.1007/s40259-019-00363-4
- ISSN : 1173-8804
- PubMed ID : 31338773